Tag: Atlas Venture

Korro Bio raised $91.5 million to run its platform of single-base RNA edits to treat a range of diseases. The Cambridge based biotech will use the cash haul toward getting its preclinical program into the clinic, while also “establishing a…

Navitor Pharmaceuticals, Inc., a Cambridge, MA-based biopharmaceutical company developing novel medicines targeting the activation of mTORC1*, completed a $33m Series B financing. he round was led by new investor Brace Pharma Capital, LLC, a strategic investment company formed by EMS…